CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,048
- in 4 filings
Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-20 | French Glendon E. III President and CEO | Sale | −5,059 | $41.01 | $207K | 1,219,825 |
| 2021-05-20 | French Glendon E. III President and CEO | Sale | −19,941 | $42.19 | $841K | 1,199,884 |
| 2021-05-20 | French Glendon E. III President and CEO | Sale | −1,000 | $40.75 | $41K | 26,571 |
| 2021-05-18 | Rose Geoffrey Beran Chief Commercial Officer | Exercise or conversion | +49,428 | $1.40 | $69K | 166,101 |
| 2021-05-18 | Rose Geoffrey Beran Chief Commercial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −49,428 | 0 | ||
| 2021-05-10 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −3,778 | $40.47 | $153K | 117,692 |
| 2021-05-10 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −900 | $41.47 | $37K | 116,792 |
| 2021-05-10 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −118 | $42.25 | $5K | 116,674 |
| 2021-05-10 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −1 | $42.51 | $43 | 116,673 |
| 2021-04-19 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −4,797 | $43.24 | $207K | 121,470 |
| 2021-04-15 | French Glendon E. III President and CEO | Exercise or conversion | +25,000 | $2.20 | $55K | 1,274,884 |
| 2021-04-15 | French Glendon E. III President and CEO | Sale | −19,989 | $43.64 | $872K | 1,254,895 |
| 2021-04-15 | French Glendon E. III President and CEO | Sale | −5,011 | $44.21 | $222K | 1,249,884 |
| 2021-04-15 | French Glendon E. III President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 184,999 | ||
| 2021-04-15 | French Glendon E. III President and CEO | Sale | −19,989 | $43.64 | $872K | 1,229,895 |
| 2021-04-15 | French Glendon E. III President and CEO | Sale | −5,011 | $44.21 | $222K | 1,224,884 |
| 2021-04-15 | French Glendon E. III President and CEO | Sale | −1,000 | $43.70 | $44K | 27,571 |
| 2021-04-06 | BOSTON SCIENTIFIC CORP 10% owner | Sale | −650,000 | $43.60 | $28.3M | 3,988,106 |
| 2021-04-06 | Sung Derrick Chief Financial Officer | Sale | −2,825 | $46.49 | $131K | 220,834 |
| 2021-04-06 | Sung Derrick Chief Financial Officer | Sale | −1,575 | $47.79 | $75K | 219,259 |
Page 21 of 23 · 450 trades